

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic sister chromatid cohesion (GO:0007064) | 3.56126986 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.36900219 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.35925438 |
| 4 | regulation of meiosis I (GO:0060631) | 3.24380559 |
| 5 | positive regulation of protein autophosphorylation (GO:0031954) | 3.21340336 |
| 6 | regulation of acrosome reaction (GO:0060046) | 3.16504854 |
| 7 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.11629986 |
| 8 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.11629986 |
| 9 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.11629986 |
| 10 | genitalia morphogenesis (GO:0035112) | 3.08531802 |
| 11 | locomotory exploration behavior (GO:0035641) | 3.01234567 |
| 12 | oocyte development (GO:0048599) | 2.98341829 |
| 13 | paraxial mesoderm development (GO:0048339) | 2.93535829 |
| 14 | interkinetic nuclear migration (GO:0022027) | 2.92016263 |
| 15 | regulation of Rac protein signal transduction (GO:0035020) | 2.88212071 |
| 16 | glutamate secretion (GO:0014047) | 2.86661484 |
| 17 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.85101812 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.83804036 |
| 19 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.82837505 |
| 20 | protein targeting to Golgi (GO:0000042) | 2.81522398 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.80114085 |
| 22 | regulation of ARF protein signal transduction (GO:0032012) | 2.79120095 |
| 23 | nuclear pore organization (GO:0006999) | 2.76298751 |
| 24 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.74995720 |
| 25 | retinal cone cell development (GO:0046549) | 2.74989876 |
| 26 | anterior/posterior axis specification, embryo (GO:0008595) | 2.73869425 |
| 27 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71436384 |
| 28 | nuclear pore complex assembly (GO:0051292) | 2.71184447 |
| 29 | synaptic vesicle maturation (GO:0016188) | 2.70358560 |
| 30 | pericardium development (GO:0060039) | 2.68634027 |
| 31 | embryonic foregut morphogenesis (GO:0048617) | 2.66756045 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.64038346 |
| 33 | protein K11-linked deubiquitination (GO:0035871) | 2.63643131 |
| 34 | establishment of protein localization to Golgi (GO:0072600) | 2.59644792 |
| 35 | smooth muscle tissue development (GO:0048745) | 2.58439958 |
| 36 | vocalization behavior (GO:0071625) | 2.57795552 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.56593125 |
| 38 | sister chromatid cohesion (GO:0007062) | 2.55816069 |
| 39 | Golgi to endosome transport (GO:0006895) | 2.51156264 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 2.50441612 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.49785016 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 2.49691673 |
| 43 | vesicle transport along microtubule (GO:0047496) | 2.49040907 |
| 44 | hippo signaling (GO:0035329) | 2.48157498 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47564322 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 2.47562761 |
| 47 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.46361879 |
| 48 | macroautophagy (GO:0016236) | 2.44996433 |
| 49 | regulation of DNA methylation (GO:0044030) | 2.44978542 |
| 50 | synapsis (GO:0007129) | 2.44195964 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.43984736 |
| 52 | intestinal epithelial cell development (GO:0060576) | 2.43558365 |
| 53 | negative regulation of hormone metabolic process (GO:0032351) | 2.42771982 |
| 54 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.42771982 |
| 55 | synaptic vesicle exocytosis (GO:0016079) | 2.41582352 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.41519579 |
| 57 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.40480671 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.39954764 |
| 59 | innervation (GO:0060384) | 2.39767639 |
| 60 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.39458404 |
| 61 | negative regulation of DNA repair (GO:0045738) | 2.39399265 |
| 62 | regulation of DNA endoreduplication (GO:0032875) | 2.38846385 |
| 63 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.38163413 |
| 64 | regulation of cardioblast differentiation (GO:0051890) | 2.37495164 |
| 65 | detection of calcium ion (GO:0005513) | 2.37463848 |
| 66 | centrosome duplication (GO:0051298) | 2.37363583 |
| 67 | female gamete generation (GO:0007292) | 2.37295146 |
| 68 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.36558804 |
| 69 | meiotic cell cycle (GO:0051321) | 2.36270859 |
| 70 | lymphangiogenesis (GO:0001946) | 2.36092463 |
| 71 | synaptic transmission, glutamatergic (GO:0035249) | 2.34558414 |
| 72 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.33545125 |
| 73 | regulation of keratinocyte proliferation (GO:0010837) | 2.33296657 |
| 74 | activation of protein kinase A activity (GO:0034199) | 2.33209946 |
| 75 | dendrite morphogenesis (GO:0048813) | 2.32718363 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.32709505 |
| 77 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.30513228 |
| 78 | regulation of beta-amyloid formation (GO:1902003) | 2.30333220 |
| 79 | regulation of centriole replication (GO:0046599) | 2.29715084 |
| 80 | COPII vesicle coating (GO:0048208) | 2.29376894 |
| 81 | establishment of nucleus localization (GO:0040023) | 2.28107270 |
| 82 | early endosome to late endosome transport (GO:0045022) | 2.28027826 |
| 83 | nodal signaling pathway (GO:0038092) | 2.27956384 |
| 84 | neuron-neuron synaptic transmission (GO:0007270) | 2.27022201 |
| 85 | establishment of chromosome localization (GO:0051303) | 2.25708375 |
| 86 | metaphase plate congression (GO:0051310) | 2.25486725 |
| 87 | positive regulation of meiosis (GO:0045836) | 2.25379847 |
| 88 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.24893765 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 2.23515568 |
| 90 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.23484899 |
| 91 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.22860213 |
| 92 | piRNA metabolic process (GO:0034587) | 2.22685865 |
| 93 | dorsal/ventral axis specification (GO:0009950) | 2.22305324 |
| 94 | chemosensory behavior (GO:0007635) | 2.22146784 |
| 95 | artery development (GO:0060840) | 2.22035739 |
| 96 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.21948191 |
| 97 | proline transport (GO:0015824) | 2.19427986 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 2.18287551 |
| 99 | neurotransmitter secretion (GO:0007269) | 2.18262884 |
| 100 | positive regulation of chromosome segregation (GO:0051984) | 2.18096609 |
| 101 | inner ear receptor cell development (GO:0060119) | 2.17961036 |
| 102 | positive regulation of vesicle fusion (GO:0031340) | 2.17880483 |
| 103 | positive regulation of macroautophagy (GO:0016239) | 2.17235440 |
| 104 | desmosome organization (GO:0002934) | 2.16751252 |
| 105 | neuronal action potential propagation (GO:0019227) | 2.16281388 |
| 106 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.15827050 |
| 107 | insulin secretion (GO:0030073) | 2.14482830 |
| 108 | mating behavior (GO:0007617) | 2.14249923 |
| 109 | histone-serine phosphorylation (GO:0035404) | 2.14125720 |
| 110 | presynaptic membrane assembly (GO:0097105) | 2.14000059 |
| 111 | relaxation of cardiac muscle (GO:0055119) | 2.13091134 |
| 112 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.12610572 |
| 113 | positive regulation of meiotic cell cycle (GO:0051446) | 2.12539939 |
| 114 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.11598730 |
| 115 | somite rostral/caudal axis specification (GO:0032525) | 2.11166967 |
| 116 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.10965164 |
| 117 | layer formation in cerebral cortex (GO:0021819) | 2.10755122 |
| 118 | regulation of postsynaptic membrane potential (GO:0060078) | 2.10451415 |
| 119 | prenylation (GO:0097354) | 2.09889165 |
| 120 | protein prenylation (GO:0018342) | 2.09889165 |
| 121 | fibroblast migration (GO:0010761) | 2.09621338 |
| 122 | neuron cell-cell adhesion (GO:0007158) | 2.09112774 |
| 123 | mitotic metaphase plate congression (GO:0007080) | 2.08865107 |
| 124 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.08807075 |
| 125 | regulation of pigment cell differentiation (GO:0050932) | 2.08531426 |
| 126 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.08221934 |
| 127 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.08046526 |
| 128 | suckling behavior (GO:0001967) | 2.07607838 |
| 129 | long-term synaptic potentiation (GO:0060291) | 2.07600141 |
| 130 | long term synaptic depression (GO:0060292) | 2.07196993 |
| 131 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.07086306 |
| 132 | embryonic axis specification (GO:0000578) | 2.06659474 |
| 133 | startle response (GO:0001964) | 2.06346997 |
| 134 | regulation of meiosis (GO:0040020) | 2.06207828 |
| 135 | protein localization to synapse (GO:0035418) | 2.06069057 |
| 136 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.05158645 |
| 137 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.05071306 |
| 138 | potassium ion import (GO:0010107) | 2.05014360 |
| 139 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.04724216 |
| 140 | glycine transport (GO:0015816) | 2.04519443 |
| 141 | NLS-bearing protein import into nucleus (GO:0006607) | 2.04472322 |
| 142 | gamma-aminobutyric acid transport (GO:0015812) | 2.02734887 |
| 143 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.02425642 |
| 144 | positive regulation of muscle hypertrophy (GO:0014742) | 2.02268684 |
| 145 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.02268684 |
| 146 | cell communication by electrical coupling (GO:0010644) | 2.01907749 |
| 147 | regulation of female gonad development (GO:2000194) | 2.01840155 |
| 148 | nerve growth factor signaling pathway (GO:0038180) | 2.01240726 |
| 149 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.00908504 |
| 150 | dendritic spine morphogenesis (GO:0060997) | 2.00838897 |
| 151 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.00653054 |
| 152 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 1.99838136 |
| 153 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 1.99548944 |
| 154 | multicellular organism reproduction (GO:0032504) | 1.99507734 |
| 155 | centriole replication (GO:0007099) | 1.99212509 |
| 156 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.98640935 |
| 157 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 1.97711179 |
| 158 | long-term memory (GO:0007616) | 1.97533133 |
| 159 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.97314557 |
| 160 | positive regulation of glycolytic process (GO:0045821) | 1.97070539 |
| 161 | cytoplasmic mRNA processing body assembly (GO:0033962) | 1.96763363 |
| 162 | membrane depolarization during action potential (GO:0086010) | 1.96745848 |
| 163 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.96511578 |
| 164 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.96225344 |
| 165 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 1.96182009 |
| 166 | microtubule anchoring (GO:0034453) | 1.95916063 |
| 167 | positive regulation of cardiac muscle tissue development (GO:0055025) | 1.95518807 |
| 168 | positive regulation of potassium ion transport (GO:0043268) | 1.95260938 |
| 169 | keratinocyte development (GO:0003334) | 1.95206452 |
| 170 | face morphogenesis (GO:0060325) | 1.95107783 |
| 171 | nucleus localization (GO:0051647) | 1.94114122 |
| 172 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.94018210 |
| 173 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 1.93510304 |
| 174 | calcium ion import (GO:0070509) | 1.93112602 |
| 175 | embryonic pattern specification (GO:0009880) | 1.93042477 |
| 176 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.93008589 |
| 177 | cytoskeleton-dependent cytokinesis (GO:0061640) | 1.92225928 |
| 178 | regulation of centrosome cycle (GO:0046605) | 1.92188484 |
| 179 | neuron recognition (GO:0008038) | 1.91995415 |
| 180 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 1.91710815 |
| 181 | phospholipid homeostasis (GO:0055091) | 1.91451676 |
| 182 | regulation of vesicle fusion (GO:0031338) | 1.91376506 |
| 183 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.90344648 |
| 184 | organelle transport along microtubule (GO:0072384) | 1.89509710 |
| 185 | exploration behavior (GO:0035640) | 1.87829619 |
| 186 | ER overload response (GO:0006983) | 1.87649537 |
| 187 | membrane repolarization during action potential (GO:0086011) | 1.87630074 |
| 188 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.87400072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25736135 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.97884677 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.96846833 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.04508982 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98033945 |
| 6 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.91951303 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.88254834 |
| 8 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87083109 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85814972 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84586359 |
| 11 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83840690 |
| 12 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81019676 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79799476 |
| 14 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79444083 |
| 15 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77689997 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76411582 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74721028 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73344079 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66670139 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66030931 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63786987 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61069100 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60346046 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60346046 |
| 25 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.60265064 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59041984 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59015965 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57706609 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57558069 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56018118 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.55590806 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.54124519 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54000579 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53840372 |
| 35 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.53693227 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53180033 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.52572921 |
| 38 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50186616 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48881078 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48011407 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45145829 |
| 42 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.44214411 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43503975 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43220512 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41441599 |
| 46 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41354121 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39561475 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38909704 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38689811 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37825193 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36591886 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35133192 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35133192 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34486751 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34107051 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34016771 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31761439 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31465395 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31060871 |
| 60 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.30962873 |
| 61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30461826 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30429235 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30334111 |
| 64 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.29785490 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28974264 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28204073 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28204073 |
| 68 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.28051247 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27776404 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27175521 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26129375 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25456436 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25275958 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24863501 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24621205 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24282630 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24228102 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23840476 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23590497 |
| 80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.23013087 |
| 81 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22998779 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22273265 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21309062 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20974084 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20831807 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19246773 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18772152 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18300147 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17245773 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16485621 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 1.16394063 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15910768 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15184154 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14407575 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14209707 |
| 96 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14037976 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13821538 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13721222 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12859398 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12841496 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12168454 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11465614 |
| 103 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11363549 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10751743 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10391971 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10364324 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10009322 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09981228 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08749891 |
| 110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08556683 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07843082 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07143990 |
| 113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06874921 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06142901 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05521487 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05251030 |
| 117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04368302 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04185983 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03772263 |
| 120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03064676 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02085564 |
| 122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00758554 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00532546 |
| 124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00267526 |
| 125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99841695 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99657562 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99424070 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99424070 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98897625 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98496221 |
| 131 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98272242 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98100761 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98080555 |
| 134 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96819731 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96082360 |
| 136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95240528 |
| 137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94225571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.77378690 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.58243418 |
| 3 | MP0008057_abnormal_DNA_replication | 3.36572924 |
| 4 | MP0004270_analgesia | 2.79471609 |
| 5 | MP0003941_abnormal_skin_development | 2.70886088 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 2.63765724 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.61102877 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.44170483 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.26472030 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.21877664 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.14472399 |
| 12 | MP0003718_maternal_effect | 2.08383722 |
| 13 | MP0010678_abnormal_skin_adnexa | 2.00760193 |
| 14 | MP0010386_abnormal_urinary_bladder | 1.97060865 |
| 15 | * MP0002063_abnormal_learning/memory/cond | 1.92797456 |
| 16 | * MP0009745_abnormal_behavioral_response | 1.90787497 |
| 17 | MP0003045_fibrosis | 1.90530544 |
| 18 | MP0003880_abnormal_central_pattern | 1.88041439 |
| 19 | MP0005275_abnormal_skin_tensile | 1.85719963 |
| 20 | MP0003252_abnormal_bile_duct | 1.84433105 |
| 21 | MP0009046_muscle_twitch | 1.84003131 |
| 22 | MP0003787_abnormal_imprinting | 1.83401250 |
| 23 | MP0001299_abnormal_eye_distance/ | 1.81864705 |
| 24 | MP0000569_abnormal_digit_pigmentation | 1.81829622 |
| 25 | MP0002822_catalepsy | 1.80926902 |
| 26 | MP0001486_abnormal_startle_reflex | 1.78860257 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.74115319 |
| 28 | MP0004043_abnormal_pH_regulation | 1.73712019 |
| 29 | MP0002064_seizures | 1.71667042 |
| 30 | MP0005365_abnormal_bile_salt | 1.69796626 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.69750489 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.68042931 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.67826006 |
| 34 | MP0005360_urolithiasis | 1.67315602 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.64409260 |
| 36 | MP0006054_spinal_hemorrhage | 1.64337715 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.62458002 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.61962523 |
| 39 | * MP0002572_abnormal_emotion/affect_behav | 1.61214108 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.58310882 |
| 41 | MP0003690_abnormal_glial_cell | 1.57662154 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.53892130 |
| 43 | MP0005409_darkened_coat_color | 1.52208634 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.51654514 |
| 45 | * MP0002272_abnormal_nervous_system | 1.51633873 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.50712424 |
| 47 | * MP0000427_abnormal_hair_cycle | 1.50116951 |
| 48 | MP0000383_abnormal_hair_follicle | 1.46660064 |
| 49 | MP0003937_abnormal_limbs/digits/tail_de | 1.46315814 |
| 50 | MP0004130_abnormal_muscle_cell | 1.39385977 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.38749459 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.36649982 |
| 53 | MP0003283_abnormal_digestive_organ | 1.36553494 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.36189591 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.35383356 |
| 56 | MP0005395_other_phenotype | 1.35037354 |
| 57 | MP0001177_atelectasis | 1.27997329 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.27109576 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.25556659 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.25014780 |
| 61 | MP0004272_abnormal_basement_membrane | 1.24475164 |
| 62 | MP0003195_calcinosis | 1.23791678 |
| 63 | MP0003868_abnormal_feces_composition | 1.21068750 |
| 64 | MP0009697_abnormal_copulation | 1.21053599 |
| 65 | MP0003329_amyloid_beta_deposits | 1.16467065 |
| 66 | MP0005171_absent_coat_pigmentation | 1.16005856 |
| 67 | MP0004885_abnormal_endolymph | 1.15595461 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.15571467 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.15565434 |
| 70 | * MP0001502_abnormal_circadian_rhythm | 1.13856478 |
| 71 | MP0001968_abnormal_touch/_nociception | 1.13436443 |
| 72 | MP0002108_abnormal_muscle_morphology | 1.13355498 |
| 73 | MP0002160_abnormal_reproductive_system | 1.13020890 |
| 74 | MP0003633_abnormal_nervous_system | 1.11950746 |
| 75 | MP0005248_abnormal_Harderian_gland | 1.11460076 |
| 76 | * MP0002078_abnormal_glucose_homeostasis | 1.10797900 |
| 77 | MP0003935_abnormal_craniofacial_develop | 1.10395788 |
| 78 | MP0005187_abnormal_penis_morphology | 1.10371195 |
| 79 | MP0008569_lethality_at_weaning | 1.08502477 |
| 80 | MP0000762_abnormal_tongue_morphology | 1.06299647 |
| 81 | MP0002229_neurodegeneration | 1.06151052 |
| 82 | MP0001440_abnormal_grooming_behavior | 1.05741956 |
| 83 | MP0002090_abnormal_vision | 1.05603582 |
| 84 | MP0002233_abnormal_nose_morphology | 1.03907410 |
| 85 | MP0002693_abnormal_pancreas_physiology | 1.03692341 |
| 86 | MP0001944_abnormal_pancreas_morphology | 1.03676058 |
| 87 | MP0003755_abnormal_palate_morphology | 1.03436839 |
| 88 | MP0000749_muscle_degeneration | 1.02548215 |
| 89 | * MP0005386_behavior/neurological_phenoty | 1.00695321 |
| 90 | * MP0004924_abnormal_behavior | 1.00695321 |
| 91 | MP0003950_abnormal_plasma_membrane | 1.00233047 |
| 92 | MP0003879_abnormal_hair_cell | 0.99948440 |
| 93 | MP0003631_nervous_system_phenotype | 0.99929371 |
| 94 | MP0010307_abnormal_tumor_latency | 0.99823416 |
| 95 | MP0003632_abnormal_nervous_system | 0.99639681 |
| 96 | * MP0005535_abnormal_body_temperature | 0.99356350 |
| 97 | MP0010329_abnormal_lipoprotein_level | 0.98670513 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.96403720 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.95475154 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.94998813 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.94509535 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.94341710 |
| 103 | MP0001984_abnormal_olfaction | 0.94320692 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.93394064 |
| 105 | MP0002733_abnormal_thermal_nociception | 0.93309622 |
| 106 | MP0000920_abnormal_myelination | 0.92486224 |
| 107 | MP0000647_abnormal_sebaceous_gland | 0.92265886 |
| 108 | MP0002084_abnormal_developmental_patter | 0.91575911 |
| 109 | MP0000428_abnormal_craniofacial_morphol | 0.91314395 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.90963064 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.89945679 |
| 112 | MP0002168_other_aberrant_phenotype | 0.89717787 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.88220184 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.88206229 |
| 115 | MP0000778_abnormal_nervous_system | 0.87616894 |
| 116 | MP0002009_preneoplasia | 0.87376016 |
| 117 | MP0008775_abnormal_heart_ventricle | 0.86781603 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.86355538 |
| 119 | MP0002060_abnormal_skin_morphology | 0.84880756 |
| 120 | MP0001970_abnormal_pain_threshold | 0.84537185 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.84412463 |
| 122 | * MP0002118_abnormal_lipid_homeostasis | 0.83956911 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.83767624 |
| 124 | * MP0002882_abnormal_neuron_morphology | 0.82798389 |
| 125 | MP0004134_abnormal_chest_morphology | 0.81967872 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.81895881 |
| 127 | MP0000432_abnormal_head_morphology | 0.81885492 |
| 128 | MP0002971_abnormal_brown_adipose | 0.81613975 |
| 129 | MP0005253_abnormal_eye_physiology | 0.81503408 |
| 130 | MP0002735_abnormal_chemical_nociception | 0.80850068 |
| 131 | MP0000751_myopathy | 0.80245758 |
| 132 | MP0003091_abnormal_cell_migration | 0.80186126 |
| 133 | MP0004484_altered_response_of | 0.80102413 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.80034407 |
| 135 | MP0003119_abnormal_digestive_system | 0.79956391 |
| 136 | * MP0002066_abnormal_motor_capabilities/c | 0.79337587 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.78629665 |
| 138 | MP0005670_abnormal_white_adipose | 0.78463993 |
| 139 | MP0000733_abnormal_muscle_development | 0.78193220 |
| 140 | MP0002177_abnormal_outer_ear | 0.77402933 |
| 141 | MP0000462_abnormal_digestive_system | 0.76992384 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.75762186 |
| 143 | MP0002269_muscular_atrophy | 0.75239150 |
| 144 | MP0003385_abnormal_body_wall | 0.74691190 |
| 145 | MP0010030_abnormal_orbit_morphology | 0.73534707 |
| 146 | MP0001929_abnormal_gametogenesis | 0.72618934 |
| 147 | MP0002102_abnormal_ear_morphology | 0.72294853 |
| 148 | MP0008058_abnormal_DNA_repair | 0.71809660 |
| 149 | MP0005620_abnormal_muscle_contractility | 0.70904562 |
| 150 | * MP0004085_abnormal_heartbeat | 0.70571243 |
| 151 | MP0003121_genomic_imprinting | 0.70355167 |
| 152 | MP0000516_abnormal_urinary_system | 0.69404708 |
| 153 | MP0005367_renal/urinary_system_phenotyp | 0.69404708 |
| 154 | MP0001672_abnormal_embryogenesis/_devel | 0.69300929 |
| 155 | MP0005380_embryogenesis_phenotype | 0.69300929 |
| 156 | MP0010094_abnormal_chromosome_stability | 0.68656469 |
| 157 | MP0004233_abnormal_muscle_weight | 0.67785957 |
| 158 | MP0001286_abnormal_eye_development | 0.66451325 |
| 159 | MP0000631_abnormal_neuroendocrine_gland | 0.64927914 |
| 160 | MP0004197_abnormal_fetal_growth/weight/ | 0.64305118 |
| 161 | MP0001293_anophthalmia | 0.64063151 |
| 162 | MP0009703_decreased_birth_body | 0.64034155 |
| 163 | MP0002938_white_spotting | 0.63175931 |
| 164 | MP0002088_abnormal_embryonic_growth/wei | 0.62992240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.04026471 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.42551520 |
| 3 | Action tremor (HP:0002345) | 3.14837867 |
| 4 | Volvulus (HP:0002580) | 3.02653664 |
| 5 | Focal seizures (HP:0007359) | 2.88334217 |
| 6 | Febrile seizures (HP:0002373) | 2.86365775 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.83250339 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 2.71117014 |
| 9 | Hypoglycemic seizures (HP:0002173) | 2.70572762 |
| 10 | Macroorchidism (HP:0000053) | 2.69140226 |
| 11 | Fair hair (HP:0002286) | 2.67772576 |
| 12 | Atonic seizures (HP:0010819) | 2.66174636 |
| 13 | Hypoplastic labia majora (HP:0000059) | 2.65635794 |
| 14 | Pigmentary retinal degeneration (HP:0001146) | 2.57678909 |
| 15 | Hyperglycemia (HP:0003074) | 2.56806572 |
| 16 | Blue irides (HP:0000635) | 2.55771389 |
| 17 | Epileptic encephalopathy (HP:0200134) | 2.54113841 |
| 18 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.47533099 |
| 19 | Abnormality of the labia majora (HP:0012881) | 2.46271710 |
| 20 | Symptomatic seizures (HP:0011145) | 2.45064772 |
| 21 | Central scotoma (HP:0000603) | 2.40430251 |
| 22 | Excessive salivation (HP:0003781) | 2.39277604 |
| 23 | Drooling (HP:0002307) | 2.39277604 |
| 24 | Visual hallucinations (HP:0002367) | 2.39217630 |
| 25 | Lip pit (HP:0100267) | 2.39193520 |
| 26 | Absence seizures (HP:0002121) | 2.39100132 |
| 27 | Enlarged penis (HP:0000040) | 2.37516436 |
| 28 | Insidious onset (HP:0003587) | 2.37124505 |
| 29 | Termporal pattern (HP:0011008) | 2.37124505 |
| 30 | Bundle branch block (HP:0011710) | 2.36730072 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.36571582 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 2.35993636 |
| 33 | Papillary thyroid carcinoma (HP:0002895) | 2.33772840 |
| 34 | Bifid tongue (HP:0010297) | 2.31762704 |
| 35 | Dysdiadochokinesis (HP:0002075) | 2.29951954 |
| 36 | Hyperventilation (HP:0002883) | 2.28542490 |
| 37 | Hypoplastic ischia (HP:0003175) | 2.26353755 |
| 38 | Genetic anticipation (HP:0003743) | 2.26283941 |
| 39 | Oligodactyly (hands) (HP:0001180) | 2.25990299 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.24545460 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.22048988 |
| 42 | Abnormality of the ischium (HP:0003174) | 2.19755100 |
| 43 | Scanning speech (HP:0002168) | 2.19315068 |
| 44 | Astrocytoma (HP:0009592) | 2.18858919 |
| 45 | Abnormality of the astrocytes (HP:0100707) | 2.18858919 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.17724898 |
| 47 | Thyroid carcinoma (HP:0002890) | 2.16762537 |
| 48 | Biliary tract neoplasm (HP:0100574) | 2.15943950 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.15781517 |
| 50 | Dysmetric saccades (HP:0000641) | 2.11620325 |
| 51 | Hyperkalemia (HP:0002153) | 2.09316239 |
| 52 | Dysmetria (HP:0001310) | 2.07575343 |
| 53 | Ketoacidosis (HP:0001993) | 2.06172781 |
| 54 | Abnormal biliary tract morphology (HP:0012440) | 2.05699986 |
| 55 | Decreased circulating renin level (HP:0003351) | 2.05038939 |
| 56 | Truncal ataxia (HP:0002078) | 2.04095720 |
| 57 | Chromsome breakage (HP:0040012) | 2.03057976 |
| 58 | Vascular calcification (HP:0004934) | 2.01721295 |
| 59 | Intention tremor (HP:0002080) | 2.01587645 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01587233 |
| 61 | Absent speech (HP:0001344) | 2.00708659 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.00361460 |
| 63 | Sensory axonal neuropathy (HP:0003390) | 1.99660742 |
| 64 | Dialeptic seizures (HP:0011146) | 1.99659089 |
| 65 | Myokymia (HP:0002411) | 1.98469179 |
| 66 | Glioma (HP:0009733) | 1.97300822 |
| 67 | Skin nodule (HP:0200036) | 1.95045902 |
| 68 | Hypoglycemic coma (HP:0001325) | 1.94578111 |
| 69 | Cystic hygroma (HP:0000476) | 1.91705658 |
| 70 | Epidermoid cyst (HP:0200040) | 1.91494870 |
| 71 | Postural instability (HP:0002172) | 1.90527703 |
| 72 | Retinal atrophy (HP:0001105) | 1.88115028 |
| 73 | Urethral obstruction (HP:0000796) | 1.88008411 |
| 74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.87820804 |
| 75 | Agitation (HP:0000713) | 1.87117629 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.87098365 |
| 77 | Metaphyseal dysplasia (HP:0100255) | 1.85091880 |
| 78 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.84607569 |
| 79 | Abnormal auditory evoked potentials (HP:0006958) | 1.84408818 |
| 80 | Increased number of teeth (HP:0011069) | 1.83638994 |
| 81 | Abnormality of chromosome stability (HP:0003220) | 1.81208633 |
| 82 | Microglossia (HP:0000171) | 1.80864631 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80307210 |
| 84 | Resting tremor (HP:0002322) | 1.78088841 |
| 85 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75703799 |
| 86 | Limited hip movement (HP:0008800) | 1.75494009 |
| 87 | Broad-based gait (HP:0002136) | 1.75410386 |
| 88 | Rhabdomyosarcoma (HP:0002859) | 1.75284763 |
| 89 | Subacute progressive viral hepatitis (HP:0006572) | 1.75104485 |
| 90 | Abnormality of abdominal situs (HP:0011620) | 1.75082654 |
| 91 | Abdominal situs inversus (HP:0003363) | 1.75082654 |
| 92 | Labial hypoplasia (HP:0000066) | 1.74415694 |
| 93 | Absent frontal sinuses (HP:0002688) | 1.74385051 |
| 94 | Neoplasm of the small intestine (HP:0100833) | 1.73696819 |
| 95 | Pheochromocytoma (HP:0002666) | 1.72387489 |
| 96 | Popliteal pterygium (HP:0009756) | 1.72204938 |
| 97 | Depression (HP:0000716) | 1.71931290 |
| 98 | Knee flexion contracture (HP:0006380) | 1.71651556 |
| 99 | Intrahepatic cholestasis (HP:0001406) | 1.71524741 |
| 100 | Generalized hypopigmentation of hair (HP:0011358) | 1.70784363 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 1.70695273 |
| 102 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.70695273 |
| 103 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70695273 |
| 104 | Calf muscle hypertrophy (HP:0008981) | 1.70556998 |
| 105 | Complement deficiency (HP:0004431) | 1.70307916 |
| 106 | Syncope (HP:0001279) | 1.69379543 |
| 107 | Onion bulb formation (HP:0003383) | 1.69307640 |
| 108 | Cubitus valgus (HP:0002967) | 1.69042501 |
| 109 | Prolonged QT interval (HP:0001657) | 1.68170812 |
| 110 | Abnormal social behavior (HP:0012433) | 1.67842870 |
| 111 | Impaired social interactions (HP:0000735) | 1.67842870 |
| 112 | Abnormality of the calf musculature (HP:0001430) | 1.66940203 |
| 113 | Arterial tortuosity (HP:0005116) | 1.65306267 |
| 114 | Capillary hemangiomas (HP:0005306) | 1.65001632 |
| 115 | Abnormal pancreas size (HP:0012094) | 1.64986516 |
| 116 | Increased circulating renin level (HP:0000848) | 1.64668099 |
| 117 | Truncal obesity (HP:0001956) | 1.64214731 |
| 118 | Turricephaly (HP:0000262) | 1.63170349 |
| 119 | Double outlet right ventricle (HP:0001719) | 1.62271253 |
| 120 | Congenital malformation of the right heart (HP:0011723) | 1.62271253 |
| 121 | Impaired smooth pursuit (HP:0007772) | 1.62099546 |
| 122 | Abnormality of the nasal septum (HP:0000419) | 1.61528264 |
| 123 | Hypoplastic female external genitalia (HP:0012815) | 1.61079842 |
| 124 | Abnormality of salivation (HP:0100755) | 1.60920764 |
| 125 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.60755067 |
| 126 | Abnormality of the corticospinal tract (HP:0002492) | 1.60479822 |
| 127 | Widely spaced teeth (HP:0000687) | 1.59932518 |
| 128 | Dyschromatopsia (HP:0007641) | 1.58857584 |
| 129 | Scotoma (HP:0000575) | 1.57645552 |
| 130 | Abnormality of the intrinsic pathway (HP:0010989) | 1.57459442 |
| 131 | Aneurysm (HP:0002617) | 1.57249403 |
| 132 | Hamartoma of the eye (HP:0010568) | 1.57053096 |
| 133 | Abnormality of potassium homeostasis (HP:0011042) | 1.57016297 |
| 134 | Median cleft lip (HP:0000161) | 1.56945038 |
| 135 | Overgrowth (HP:0001548) | 1.56940502 |
| 136 | Pulmonic stenosis (HP:0001642) | 1.56439049 |
| 137 | Heterotopia (HP:0002282) | 1.56246476 |
| 138 | Bradycardia (HP:0001662) | 1.56172030 |
| 139 | Decreased motor nerve conduction velocity (HP:0003431) | 1.56006366 |
| 140 | Short chin (HP:0000331) | 1.55532932 |
| 141 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.54929543 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.54807400 |
| 143 | Neoplasm of the oral cavity (HP:0100649) | 1.54735477 |
| 144 | Sensorimotor neuropathy (HP:0007141) | 1.54399949 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.53548407 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.53548407 |
| 147 | Anxiety (HP:0000739) | 1.53437706 |
| 148 | Neoplasm of the adrenal cortex (HP:0100641) | 1.53037937 |
| 149 | Vascular tortuosity (HP:0004948) | 1.53016371 |
| 150 | Narrow palate (HP:0000189) | 1.52951100 |
| 151 | Follicular hyperkeratosis (HP:0007502) | 1.52652332 |
| 152 | Embryonal renal neoplasm (HP:0011794) | 1.52517917 |
| 153 | Abnormality of macular pigmentation (HP:0008002) | 1.52175524 |
| 154 | Chorioretinal atrophy (HP:0000533) | 1.52113895 |
| 155 | Impaired vibratory sensation (HP:0002495) | 1.51531158 |
| 156 | Aqueductal stenosis (HP:0002410) | 1.51528112 |
| 157 | Curly hair (HP:0002212) | 1.51433495 |
| 158 | Bladder carcinoma (HP:0002862) | 1.51290338 |
| 159 | Bladder neoplasm (HP:0009725) | 1.51290338 |
| 160 | Congenital stationary night blindness (HP:0007642) | 1.51107271 |
| 161 | Menstrual irregularities (HP:0000858) | 1.50166532 |
| 162 | Deep philtrum (HP:0002002) | 1.48283563 |
| 163 | Abnormality of the frontal sinuses (HP:0002687) | 1.46827858 |
| 164 | Hyperphosphatemia (HP:0002905) | 1.46664298 |
| 165 | Protruding tongue (HP:0010808) | 1.46553467 |
| 166 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.45783804 |
| 167 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.45560787 |
| 168 | Hypoplastic scapulae (HP:0000882) | 1.45560787 |
| 169 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.45287985 |
| 170 | Hip contracture (HP:0003273) | 1.45215129 |
| 171 | Wrist flexion contracture (HP:0001239) | 1.44852014 |
| 172 | Short tibia (HP:0005736) | 1.43918378 |
| 173 | Aortic dissection (HP:0002647) | 1.42736911 |
| 174 | Supernumerary spleens (HP:0009799) | 1.41303421 |
| 175 | Abnormality of the labia (HP:0000058) | 1.41201682 |
| 176 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.40931328 |
| 177 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.40433257 |
| 178 | Cone-rod dystrophy (HP:0000548) | 1.40288993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 3.16360138 |
| 2 | NTRK3 | 3.13853225 |
| 3 | PRPF4B | 3.07406317 |
| 4 | INSRR | 3.05269691 |
| 5 | ACVR1B | 2.62221667 |
| 6 | FRK | 2.61819764 |
| 7 | TRIM28 | 2.39007321 |
| 8 | MAP3K4 | 2.13949007 |
| 9 | BMPR1B | 2.04994530 |
| 10 | EPHA4 | 1.92796287 |
| 11 | EIF2AK3 | 1.88969270 |
| 12 | MST4 | 1.88470004 |
| 13 | MST1R | 1.82309500 |
| 14 | MAP3K2 | 1.80166755 |
| 15 | PNCK | 1.74609831 |
| 16 | MAP3K9 | 1.64205278 |
| 17 | CAMK1G | 1.61831774 |
| 18 | STK38 | 1.60879073 |
| 19 | BRSK2 | 1.60793502 |
| 20 | PRKD3 | 1.57460233 |
| 21 | BRD4 | 1.54836070 |
| 22 | CASK | 1.54618848 |
| 23 | CAMK1D | 1.52590260 |
| 24 | MKNK2 | 1.52297702 |
| 25 | SGK2 | 1.49762011 |
| 26 | PBK | 1.46700825 |
| 27 | SGK494 | 1.44399557 |
| 28 | SGK223 | 1.44399557 |
| 29 | PAK6 | 1.43993008 |
| 30 | FER | 1.43506291 |
| 31 | DAPK2 | 1.40846589 |
| 32 | AKT3 | 1.40666121 |
| 33 | SGK3 | 1.39281198 |
| 34 | MELK | 1.33476295 |
| 35 | WNK1 | 1.31255728 |
| 36 | MAP3K12 | 1.29838543 |
| 37 | MAP2K7 | 1.28710927 |
| 38 | DMPK | 1.26260268 |
| 39 | FGFR2 | 1.24982180 |
| 40 | TAOK3 | 1.24727920 |
| 41 | CAMKK1 | 1.23204167 |
| 42 | TTK | 1.22522252 |
| 43 | NTRK1 | 1.22337625 |
| 44 | MAP2K4 | 1.21433140 |
| 45 | TRPM7 | 1.18507431 |
| 46 | OBSCN | 1.18487159 |
| 47 | MYLK | 1.16281938 |
| 48 | PRKCH | 1.16043140 |
| 49 | KSR2 | 1.11404207 |
| 50 | PAK3 | 1.10993041 |
| 51 | CAMKK2 | 1.08332219 |
| 52 | RET | 1.07851156 |
| 53 | SCYL2 | 1.07562150 |
| 54 | STK39 | 1.07169017 |
| 55 | STK38L | 1.05818198 |
| 56 | ERBB4 | 1.01618525 |
| 57 | WNK3 | 1.01298178 |
| 58 | STK24 | 1.01282755 |
| 59 | NLK | 1.00703070 |
| 60 | WNK4 | 0.99969613 |
| 61 | PDGFRA | 0.99169951 |
| 62 | WEE1 | 0.98845508 |
| 63 | NUAK1 | 0.98811904 |
| 64 | RIPK1 | 0.93840782 |
| 65 | PLK3 | 0.93711311 |
| 66 | TGFBR1 | 0.92621934 |
| 67 | KSR1 | 0.92456772 |
| 68 | PIK3CA | 0.91832713 |
| 69 | SGK1 | 0.91722214 |
| 70 | NEK9 | 0.90161453 |
| 71 | PDGFRB | 0.89517475 |
| 72 | OXSR1 | 0.87880133 |
| 73 | NTRK2 | 0.87006559 |
| 74 | CDC42BPA | 0.86220507 |
| 75 | NEK6 | 0.85253524 |
| 76 | * CDK5 | 0.84049347 |
| 77 | CAMK2A | 0.82487095 |
| 78 | FGFR1 | 0.81058471 |
| 79 | JAK1 | 0.80546090 |
| 80 | DDR2 | 0.78518103 |
| 81 | FGFR3 | 0.78062742 |
| 82 | HIPK2 | 0.77089980 |
| 83 | CAMK2D | 0.74525841 |
| 84 | EIF2AK1 | 0.73360305 |
| 85 | CDK12 | 0.72083820 |
| 86 | LATS2 | 0.71697254 |
| 87 | PRKAA1 | 0.71049363 |
| 88 | PLK2 | 0.70973711 |
| 89 | STK3 | 0.70796045 |
| 90 | EPHB1 | 0.70063759 |
| 91 | PDPK1 | 0.69563315 |
| 92 | MINK1 | 0.69346925 |
| 93 | PRKCE | 0.69011855 |
| 94 | PLK1 | 0.68171515 |
| 95 | EPHA3 | 0.67612948 |
| 96 | MARK1 | 0.67181083 |
| 97 | TAF1 | 0.65901786 |
| 98 | MAP3K13 | 0.65393456 |
| 99 | MET | 0.64031861 |
| 100 | PTK2 | 0.63626565 |
| 101 | CAMK2B | 0.63463247 |
| 102 | PDK1 | 0.62901825 |
| 103 | ROCK1 | 0.61977218 |
| 104 | STK11 | 0.61891063 |
| 105 | MAP3K6 | 0.61883311 |
| 106 | MAP3K1 | 0.60075064 |
| 107 | ATM | 0.59889790 |
| 108 | RIPK4 | 0.57946249 |
| 109 | SIK1 | 0.57496305 |
| 110 | MAPK10 | 0.56390815 |
| 111 | PRKAA2 | 0.55945063 |
| 112 | MAP3K7 | 0.55865076 |
| 113 | CSNK1G1 | 0.55438311 |
| 114 | PKN1 | 0.55183636 |
| 115 | RPS6KA3 | 0.54343038 |
| 116 | NEK1 | 0.54116819 |
| 117 | LMTK2 | 0.53740531 |
| 118 | BCR | 0.53376179 |
| 119 | CDK9 | 0.52569003 |
| 120 | GRK5 | 0.51827605 |
| 121 | BMPR2 | 0.51626329 |
| 122 | PTK6 | 0.51322046 |
| 123 | MAPK13 | 0.50687141 |
| 124 | EPHA2 | 0.49312701 |
| 125 | BRSK1 | 0.49311884 |
| 126 | BUB1 | 0.49230991 |
| 127 | PHKG2 | 0.49141814 |
| 128 | PHKG1 | 0.49141814 |
| 129 | CSNK1A1L | 0.48637484 |
| 130 | PINK1 | 0.48124357 |
| 131 | ERBB3 | 0.47390631 |
| 132 | EIF2AK2 | 0.47241742 |
| 133 | PRKCG | 0.46586599 |
| 134 | GSK3A | 0.46463351 |
| 135 | MAP4K2 | 0.46277728 |
| 136 | CSNK1G2 | 0.45805823 |
| 137 | MAPK15 | 0.45718491 |
| 138 | TNIK | 0.45331301 |
| 139 | PTK2B | 0.45019139 |
| 140 | YES1 | 0.44798112 |
| 141 | MKNK1 | 0.39073854 |
| 142 | GRK1 | 0.38403169 |
| 143 | MTOR | 0.38076987 |
| 144 | CHEK1 | 0.37613803 |
| 145 | PRKCI | 0.37425972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04438943 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 1.95664568 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 1.92204371 |
| 4 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.82769346 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.80437487 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73942224 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67242702 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66181865 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65150083 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.64172373 |
| 11 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.63453736 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62880716 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.62362856 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60275305 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.58629973 |
| 16 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.57770280 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55711344 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.48951656 |
| 19 | Tight junction_Homo sapiens_hsa04530 | 1.47294258 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.46428100 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44165593 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40253596 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37262751 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.36204244 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.36134566 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35953576 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.33670169 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.33280732 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32970256 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30596446 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.29061288 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.26024064 |
| 33 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20751033 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20547256 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20544037 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19170900 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18032550 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13517889 |
| 39 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.12060374 |
| 40 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.11355770 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.10813348 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10384817 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09210624 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08240827 |
| 45 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.08126310 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07098748 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06589595 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06508145 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05158063 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04929521 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 1.04468592 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.04274562 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02957873 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02950959 |
| 55 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.01101497 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00818923 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00764669 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99824159 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98901394 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97840216 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97509387 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95817600 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95373939 |
| 64 | Melanoma_Homo sapiens_hsa05218 | 0.94786932 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93966918 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93005589 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.91990688 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91475388 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91016417 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90091653 |
| 71 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.89518574 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88991900 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86292175 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84527147 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84014051 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81824155 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.81334707 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78917016 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78003184 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77551298 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77375282 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77137354 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.76968325 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76016295 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.75556867 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75355910 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.74860602 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73545975 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73241450 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72966149 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72927437 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72224863 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.71376291 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70722461 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.68440116 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68031369 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67561052 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67421015 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67299567 |
| 100 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.66787697 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66169979 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65636908 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64552554 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.64493486 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63782063 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62808973 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.62527010 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.61332900 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61256722 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.60940068 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60578254 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60283886 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.59889273 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59484314 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59332152 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57300486 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56932755 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55875953 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54713281 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.54591708 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54125896 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52211090 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51971678 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50725617 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49976256 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49227539 |
| 127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49207271 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49173154 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49094796 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48999980 |
| 131 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47652219 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47309035 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47031858 |
| 134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45861722 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45814193 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.45514530 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43709251 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.43360133 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.42898692 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42597255 |

